48 States & Dist. of Columbia Reach Settlement with Amgen
Amgen Agreed To Pay. In a settlement announced last week, Amgen Inc. has agreed to pay $71 million to 48 states and the District of Columbia to settle allegations that the drug maker unlawfully marketed the anemia drug Aranesp and the plaque psoriasis drug Enbrel for unapproved uses. The drug maker, based in Thousand Oaks, … [Read more...] about 48 States & Dist. of Columbia Reach Settlement with Amgen
Amgen Ends Aranesp Marketing Practices
Amgen Ends Aranesp Marketing Practices. The maker of Aranesp is halting marketing practices that critics said encouraged over-use of the anemia drug. Criticism of the policies, in which Amgen paid rebates to doctors for the purchase of Aranesp, had grown along with questions about the drug's safety. Aranesp is an … [Read more...] about Amgen Ends Aranesp Marketing Practices
Enbrel Gets Stronger Infection Warnings
Enbrel Stronger Infection Warnings. Enbrel, a popular treatment for rheumatoid arthritis and psoriasis, is getting stronger warnings about serious infections associated with its use. Yesterday, Amgen and Wyeth added the strongest U.S. Food and Drug Administration (FDA) warning—the “black box”—to the prescribing information … [Read more...] about Enbrel Gets Stronger Infection Warnings
Enbrel on New Jersey Amgen Probe
New Jersey Amgen Probe. The marketing of Enbrel is the now the subject of an investigation by the New Jersey Attorney General’s Office. The Enbrel probe will look into allegations that Amgen, the maker of the psoriasis drug, instructed Enbrel sales representatives to violate patient confidentiality rules and engage in the illegal … [Read more...] about Enbrel on New Jersey Amgen Probe
Former Amgen Employees Allege HIPAA Violation in Enbrel Marketing Scheme
Enbrel Marketing Scheme Violated HIPAA. Two former Amgen employees are charging that the drug maker engaged in illegal marketing practices in an attempt to increase sales of the drug Enbrel. The former Amgen salespeople claim that they were encouraged by the company to illegally access patient records to induce insurance … [Read more...] about Former Amgen Employees Allege HIPAA Violation in Enbrel Marketing Scheme
Aranesp Lable Changes Warning
Anemia Drug Aranesp Lable Changes. Aranesp, an anemia drug often used to treat chemotherapy patients, could soon have safety information on its label updated yet again, the drug’s maker announced last week. Amgen Inc. announced that it was considering label changes for Aranesp after the results of a study done on breast … [Read more...] about Aranesp Lable Changes Warning
Amgen Attacks J&J Anaemia Drug
Anaemia Drug Safety Concerns. Amgen, the world's largest biotechnology company, is expected on Monday to launch an attack on the safety of an anaemia drug made by its rival Johnson & Johnson, the world's second-largest pharmaceuticals concern. It is unusual for drugs companies to attack each other's products publicly. Amgen's … [Read more...] about Amgen Attacks J&J Anaemia Drug
